Answers are grounded in this paper and cite their sources.
Review highlights nanotoxicology challenges across biological systems, suggesting safer-by-design principles and advanced modeling to guide safe nanomaterial application.
The emergence of nanotechnology has led to a rapid increase in intentional and unintentional exposure to engineered nanoparticles (NPs), raising significant concerns over their impact on humans, animals, and ecosystems. Nanotoxicology has evolved to assess these adverse effects, but the field faces key challenges including complex physicochemical characterization, difficulties in exposure assessment, dynamic biological interactions, and distinct regulatory gaps. To address these challenges, solutions such as the standardization of testing protocols, the adoption of advanced 3D in vitro and in silico modeling, and the implementation of “safer-by-design” principles are proposed. The development of biodegradable nanomaterials (NMs) and effective risk management further emphasizes that responsible development and interdisciplinary collaboration are essential to balance technological innovation with human and environmental safety.
No takes yet. Share an insight, caveat, or question.
Boudjouraf et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: